Through our ongoing research and recent attendance at the Binaytara Foundation’s Hematology Oncology Conference in Sacramento, we've uncovered a persistent challenge: manufacturers are still falling short with coordinated provider engagement strategies.
Read MoreAs manufacturers prepare for Medicare drug price negotiations, a critical question emerges: How will your provider engagement strategy evolve when Maximum Fair Prices (MFP) take effect in 2026?
Emma BijesseAt HMP Market Access Insights, we’re lucky to have a team of experts dedicated to uncovering meaningful insights in the oncology space. One of those experts is Dan, whose work is shaping how we approach community oncology research.
Daniel BuchenbergerAs IDNs face increasing complexity in oncology management, having a strategic approach backed by actionable insights is critical. Our dataset doesn’t just offer data—it equips your teams with the tools to anticipate challenges and seize opportunities.
Emma Bijesse